Compound feed for poultry contains herbal raw materials
Necrotic Enterititis NE cause a significant loses among poultry and pig. According to the literature Clostridium perfingens CP is responsible for NE. NE widely accuring disease around the world. AGP ban increases the frequency of NE.
|Clostridium perfingens||Pathogen bacteria||1.0 kg/t feed|
|Clostridium rectum||1.5 kg/t feed|
|E. coli||2.0 kg/t feed|
|Staphylococcus aureus||1.2 kg/t feed|
|Streptococcus agalactiae||0.8 kg/t feed|
|Lactobacillus acidophylus||Good bacteria||15 kg/t feed|
|Lactobacillus lactis||10-15 kg/t feed|
|Bifiobacterium animalis||12 kg/t feed|
|Bifiobacterium lactis||15 kg/t feed|
|Shaccharomyces cerevisiae||15 kg/t feed|
A NEW ORGANIC PREVENTION AGAINST BACTERIAL ENTERITIS
|Starting bird number||18000||18360|
|Starting body weight||719 kg||739 kg|
|Bird weigh||39,9 g||40,2 g|
|Finishing bird number||17045||17720|
|Finishing body weight||34945 kg||38050 kg|
|Bird weight at the slaughtering||2,05 kg||2,15 kg|
|Total feed intake||63000 kg||65000 kg|
RECOMMENDATION OF USE:
In starter and grower feed, or if necessary from the beginning of feeding, until the slaughtering.
100g HERBANOPLEX / 100kg of feed
In the framework of the Central Hungarian Operational Program (Közép-Magyarországi Operatív Program), Dr. BATA Hungarian Canadian Biotechnology Research Development Ltd. was awarded 97 500 000 HUF of subsidies from EU and domestic central budget sources to develop environmentally friendly, food- safety-precision trace element of premixes for the commercial livestock.
The project’s total budget is 150 million HUF.
Our company completed the project KMOP-1.1.1-07/1-2008-0013 on the 31st May 2011.Continue reading
The Dr. Bata Ltd. won 318.66 million HUF non-refundable funding on the project “Funding for market-oriented research and development”. The investment budget of 480.33 million HUF helped to develop a complex, biotechnology based, acid-resistant, protected NSP enzymproduct development of probiotic effect. Throughout this project the solution was found for the economical and environment friendly treatment and utilization of biological, rich in fiber by-products.Continue reading
In the framework of the Central Hungarian Operational Program, the Dr BATA Hungarian Canadian Biotechnology Research Development Ltd. was awarded 115 million HUF in support of the project "Support for Enterprise Innovation". In the framework of the project, we applied for the development of a herbal combination-based product family against digestive diseases in pigs and help for the market access of the developed product. The total budget of the project was 255.56 million HUF.Continue reading